SC
SRNE

Sculptor Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Sculptor Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,600
Closed -$40K – 1458
2021
Q4 		$40K Hold
8,600
– – ﹤0.01% 1087
2021
Q3 		$66K Buy
+8,600
New +$72.9K ﹤0.01% 894
2021
Q1 		– Sell
-134,900
Closed -$921K – 850
2020
Q4 		$921K Sell
134,900
-3,300
-2% -$26.5K 0.01% 357
2020
Q3 		$1.54M Buy
138,200
+32,500
+31% +$297K 0.02% 249
2020
Q2 		$664K Buy
+105,700
New +$405K 0.01% 216
2018
Q4 		– Sell
-38,100
Closed -$168K – 323
2018
Q3 		$168K Sell
38,100
-114,600
-75% -$635K ﹤0.01% 241
2018
Q2 		$1.1M Buy
+152,700
New +$1.04M 0.01% 192

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return